About the Authors
- David Mead
-
Affiliations Lucigen Corporation, Middleton, Wisconsin, United States of America, C5•6 Technologies, Middleton, Wisconsin, United States of America, DOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Colleen Drinkwater
-
Affiliations Lucigen Corporation, Middleton, Wisconsin, United States of America, DOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Phillip J. Brumm
-
* E-mail: pbrumm@c56technologies.com
Affiliations C5•6 Technologies, Middleton, Wisconsin, United States of America, DOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts: Colleen Drinkwater, and David Mead are employed by Lucigen Corp., a manufacturer of research reagents. Phillip Brumm is employed by C5–6 Technologies Corp., an enzyme discovery company. All work reported here was performed under and supported by subcontract to the GLBRC. No funds from either corporation was used for this research or to support the researchers during performance of this work. The commercial affiliations which the authors have declared do not alter their adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DM PJB. Performed the experiments: CD PJB. Analyzed the data: DM PJB CD. Wrote the paper: PJB DM.